Trade Summary

1 week ago, Matsuda Masaru, serving as See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,230 shares at $26.12 per share, for a total transaction value of $32,123.66. Following this transaction, Matsuda Masaru now holds 126,171 shares of ARQT.

This sale represents a 0.97% decrease in Matsuda Masaru's stake in the company.

The trade was executed on Monday, August 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 6, 2026 (accepted Aug 5, 9:42 PM ET), 3 days after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.